# Equillium

Equillium is an other based in La Jolla, United States.

## Overview

- **Organization type:** other
- **Headquarters:** La Jolla, United States
- **Region:** North America
- **Address:** La Jolla, CA, United States
- **Assets under management:** Undisclosed
- **Website:** equilliumbio.com

## Regulatory record

- **Reports private funds:** No

## About

Equillium is a biotechnology company based in San Diego, United States, founded in 2017. It focuses on developing products for autoimmune and inflammatory disorders. The company has secured $65 million in total funding.

## Sectors

- Biotech
- Pharmaceuticals

## Questions

### What is Equillium's primary therapeutic focus?

Equillium focuses on severe autoimmune and inflammatory disorders with high unmet medical need, specifically targeting barrier organ diseases through its lead program EQ504 and its multi-cytokine inhibitor platform (per company website).

### How does EQ504's mechanism differ from existing autoimmune treatments?

EQ504 is a potent and selective AhR modulator with a multi-modal, non-immunosuppressive mechanism. It aims to restore immune balance by maintaining barrier function, promoting tissue repair, and regulating resident immune cells, rather than broadly suppressing the immune system (per company website).

### What is Equillium's multi-cytokine inhibitor platform?

The platform uses first-in-class structured-domain peptides that selectively inhibit multiple disease-driving cytokines while leaving other immune regulatory pathways intact. This is designed to target inflammatory conditions without the side effects of broader immunosuppression (per company website).

### What pipeline programs does Equillium have beyond EQ504?

Beyond EQ504, Equillium is developing EQ302, which is part of its multi-cytokine inhibitor platform. Additional details on other pipeline candidates are not publicly disclosed (per company website).

## Related profiles

- [The AMP Community](https://altss.com/profile/the-amp-community)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/equillium

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology